Most Recent

image: Frank Bradke: Privy to Axon Growth

Frank Bradke: Privy to Axon Growth

By | December 1, 2011

Full Professor and Senior Research Group Leader, German Center for Neurodegenerative Diseases. Age: 42

5 Comments

image: Seirian Sumner: Wasp Whisperer

Seirian Sumner: Wasp Whisperer

By | August 1, 2011

Research Fellow, Institute of Zoology, London. Age: 37

0 Comments

image: Harmit Malik: Viral Historian

Harmit Malik: Viral Historian

By | July 1, 2011

Member, Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. Age: 38

3 Comments

image: Dominique Bergmann: Probing Plant Pores

Dominique Bergmann: Probing Plant Pores

By | June 3, 2011

Assistant Professor, Department of Biology, Stanford University. Age: 41

0 Comments

image: Andrew Carter: Dynein Trailblazer

Andrew Carter: Dynein Trailblazer

By | May 25, 2011

Group Leader, Laboratory of Molecular Biology, Medical Research Council. Age: 36

0 Comments

image: Kelly Benoit-Bird: Sounding the Deep

Kelly Benoit-Bird: Sounding the Deep

By | April 1, 2011

Associate professor, College of Oceanic and Atmospheric Sciences, Oregon State University. Age: 34

0 Comments

image: Ted Cohen: Travelling for TB

Ted Cohen: Travelling for TB

By | March 1, 2011

Assistant professor, Department of Epidemiology, Harvard School of Public Health. Age: 37

0 Comments

image: Jeremy Reiter: Hunting for Cilia

Jeremy Reiter: Hunting for Cilia

By | January 1, 2011

Assistant professor of biochemistry, University of California, San Francisco. Age: 39

3 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech